Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Assembly Biosciences (ASMB) Profit After Tax: 2009-2024

Historic Profit After Tax for Assembly Biosciences (ASMB) over the last 14 years, with Dec 2024 value amounting to -$40.2 million.

  • Assembly Biosciences' Profit After Tax rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 5.53%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
  • As of FY2024, Assembly Biosciences' Profit After Tax stood at -$40.2 million, which was up 34.38% from -$61.2 million recorded in FY2023.
  • In the past 5 years, Assembly Biosciences' Profit After Tax registered a high of -$40.2 million during FY2024, and its lowest value of -$129.9 million during FY2021.
  • In the last 3 years, Assembly Biosciences' Profit After Tax had a median value of -$61.2 million in 2023 and averaged -$64.8 million.
  • In the last 5 years, Assembly Biosciences' Profit After Tax soared by 36.34% in 2020 and then crashed by 108.93% in 2021.
  • Yearly analysis of 5 years shows Assembly Biosciences' Profit After Tax stood at -$62.2 million in 2020, then plummeted by 108.93% to -$129.9 million in 2021, then climbed by 28.31% to -$93.1 million in 2022, then surged by 34.23% to -$61.2 million in 2023, then soared by 34.38% to -$40.2 million in 2024.